EnvisionTEC Teams with Somos® to Develop High-Performance Materials
EnvisionTEC is proud to announce its collaboration with DSM’s product brand Somos® , a world leader in additive manufacturing material development. The partnership will allow both companies to advance their technologies and develop new applications.
“Somos® consistently produces cutting-edge materials for 3D printing,” says John Hartner, Chief Operating Officer of EnvisionTEC. “Working together will accelerate the possibility of producing large industrial parts with a high level of performance at much faster speeds.”
Melissa Lutz, Business Director for Somos® continues, “We are very excited to be working with EnvisionTEC. Their new, 3SP® large-frame machines produce parts two to three times faster than the existing, industry-leading equipment. We can’t wait to develop high-performance materials that enable their equipment to expand into new industrial applications.”
DSM – Bright Science. Brighter Living.™ Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com .
DSM believes that 3D printing is a major change agent for the world creating brighter lives for people today and generations to come. Somos® , a product brand of DSM, moves the Additive Manufacturing industry to a new level of performance. We are dedicated to helping our customers grow in the ever-changing world of 3D Printing and promote this growth through continuous material and application development, encouraging industry collaboration and maximizing customer asset value by providing continuous information and support. More information about Somos® can be found at www.dsm.com/somos .
EnvisionTEC is a leading global provider of professional grade 3D printing solutions for the rapid manufacture of customized products utilizing its proprietary consumables across a variety of markets. Since its first patent submission in 1999, EnvisionTEC has developed and released 3D print solutions consisting of 3D printers, print materials and replacement parts, as well as training and other services. Their proprietary, multi-platform technology delivers high precision, speed, surface quality and functionality and uses a wide range of materials at high production speeds. EnvisionTEC works with a strong customer and partner bases in diverse sectors, including jewelry, hearing aid, dental, consumer, auto manufacturing and design companies. For more information, please visit EnvisionTEC.com .
Jenna Franklin, 313-436-4300
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
MA-QUADIENT25.6.2018 16:32 | pressemeddelelse
Quadient Announces General Availability of Quadient Inspire R12
DEMENTIA-DISCOVERY-FUND25.6.2018 15:02 | pressemeddelelse
The Dementia Discovery Fund Raises $350 Million
INSTITUT-CURIE25.6.2018 14:24 | pressemeddelelse
Professor Thierry Philip Takes Office as OECI President
BOEHRINGER-INGELHEIM25.6.2018 14:09 | pressemeddelelse
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
CA-GILEAD-SCIENCES25.6.2018 14:05 | pressemeddelelse
European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection
ANT-FINANCIAL/25.6.2018 14:02 | pressemeddelelse
AlipayHK and GCash Launch Cross-Border Remittance Service Powered by Alipay’s Blockchain Technology
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum